PRIMARY PERITONEAL CARCINOMA
Clinical trials for PRIMARY PERITONEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CARCINOMA trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New surgery targets hidden cancer in liver lymph nodes for ovarian patients
Disease control Recruiting nowThis study tests if removing lymph nodes near the liver (hepato-celiac lymphadenectomy) can help control advanced or recurrent ovarian cancer. About 94 women with stage III/IV or platinum-sensitive recurrent ovarian cancer will receive this surgery. Researchers will track how man…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: NA • Sponsor: Shanghai Gynecologic Oncology Group • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
Experimental CAR t therapy targets Hard-to-Treat ovarian cancers
Disease control Recruiting nowThis early-stage study tests an experimental treatment called 27T51, a type of immune cell therapy (CAR T) designed to target a protein called MUC16 found on certain cancer cells. The study involves about 90 women with ovarian, peritoneal, or fallopian tube cancer that has come b…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:59 UTC
-
New hope for Hard-to-Treat cancers: Rina-S trial opens
Disease control Recruiting nowThis study tests a drug called Rina-S in people with advanced solid tumors that have spread or can't be removed by surgery. The goal is to check safety and see if the drug shrinks tumors. About 764 participants with cancers like ovarian, lung, breast, or endometrial cancer will t…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
Personalized cell therapy targets tough ovarian cancers
Disease control Recruiting nowThis study tests a new treatment using specially engineered natural killer (NK) cells to attack cancer cells in people with ovarian, peritoneal, or fallopian tube cancer that has come back or not responded to standard treatments. The therapy is personalized based on the specific …
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Could less chemo be enough? new trial hopes to ease treatment for ovarian cancer patients
Disease control Recruiting nowThis study looks at whether women with advanced ovarian cancer who have had all visible tumor removed can safely receive only 3 cycles of chemotherapy instead of the usual 6, followed by the maintenance drug niraparib. The goal is to see if the shorter chemo course is just as eff…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE2 • Sponsor: North Eastern German Society of Gynaecological Oncology • Aim: Disease control
Last updated May 26, 2026 05:42 UTC
-
New hope for ovarian cancer: experimental drug combo enters final testing phase
Disease control Recruiting nowThis phase 3 trial tests whether adding the experimental drug IMNN-001 to standard chemotherapy helps people with advanced ovarian, fallopian tube, or primary peritoneal cancer live longer. About 500 newly diagnosed adults will receive either the drug combination or chemotherapy …
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE3 • Sponsor: Imunon • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New radioactive tracer could sharpen cancer detection
Diagnosis Recruiting nowThis study is testing a new radioactive tracer called [18F]FTT to see if it can make PET/CT scans better at finding solid tumors, including ovarian, breast, and other cancers. About 300 adults with known or suspected tumors will receive the tracer and then have a PET/CT scan. The…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 26, 2026 05:51 UTC
-
Cancer patients may soon skip clinic trips for home treatment
Symptom relief Recruiting nowThis study tests whether giving cancer treatment at home is preferred over going to a clinic. It involves 27 adults with various cancers in the Florida Panhandle. The goal is to see if home care improves patient satisfaction and is safe.
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 05:51 UTC
-
Stress-Busting combo tested in ovarian cancer surgery
Symptom relief Recruiting nowThis study tests whether a combination of two drugs (propranolol and etodolac) plus mind-body training and music therapy can reduce stress in women with advanced ovarian cancer undergoing surgery. About 35 participants will be randomly assigned to receive this bundle or standard …
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 05:43 UTC
-
Researchers launch massive data collection to unlock secrets of Low-Grade ovarian cancer
Knowledge-focused Recruiting nowThis study is gathering information and tumor samples from 2,000 people with low-grade ovarian or peritoneal tumors. The goal is to create a detailed database that helps researchers learn more about these rare cancers and how they are treated. This knowledge may lead to better tr…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC